A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2027
DOI: 10.1016/j.bbadis.2026.168495 ↗Kurz gefasst
Fallbericht in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2027. Verfasst von Zhenhui Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, 450003, Henan, China; Eye Institute, He…. Hauptthemen laut MEDLINE: Mitochondria, Mitochondrial Diseases, NADH Dehydrogenase, Optic Atrophy. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Health Commission of Henan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study identified two compound heterozygous variants in the NDUFS1 gene in a patient presenting with optic atrophy including the known variant c.64C>T p.(R22X) and a novel variant c.404G>A p.(G135D). The Ndufs1G135D/- mouse model exhibited reduced Ndufs1 expression, impaired optic nerve function and thinning of the ganglion cell complex/retinal thickness ratio. Structural and interaction analyses indicated the G135D variant located within the Fe-S cluster domain of NDUFS1, disrupted its interaction with NDUFV1, leading to protein instability and aberrant mitochondrial localization. Functional studies using NDUFS1 knockout HEK293 cells showed increased ROS, decreased mitochondrial membrane potential, reduced NAD+/NADH ratio, impaired complex I activity, decreased ATP production and defective oxidative phosphorylation. Mitochondrial dysfunction was not fully rescued by the G135D mutant protein. Collectively, the G135D variant was associated with impaired complex I-mediated electron transfer and mitochondrial dysfunction, providing insights into the pathogenesis of optic atrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, 450003, Henan, China; Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, 451162, Hena…
- Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, 451162, Henan, China.
- Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, 451162, Henan, China; People's Hospital of Henan University, Henan Provincial People's Hospital, Zhengzhou, 450003, Henan, China.
- Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, 451162, Henan, China; Department of Immunology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
- Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, 450003, Henan, China; People's Hospital of Henan University, Henan Provincial People's Hospital, Zhengzhou, 4…
Förderung
- Health Commission of Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, Z., Jin, Y., Li, Y., Fan, Y., Jin, X., Hao, B., Yao, S., & Lei, B. (2027). A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168495
Vancouver
Liu Z, Jin Y, Li Y, Fan Y, Jin X, Hao B, et al. A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2027. doi:10.1016/j.bbadis.2026.168495
BibTeX
@article{Liu2027,
author = {Liu, Zhenhui and Jin, Yujie and Li, Yan and Fan, Yiran and Jin, Xiuxiu and Hao, Bingtao and Yao, Shun and Lei, Bo},
title = {A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2027},
doi = {10.1016/j.bbadis.2026.168495}
}
EUVIMED